Robotics & Machine Learning Daily News2024,Issue(Dec.6) :73-74.

First Affiliated Hospital of Xi’an Jiaotong University Reports Findings in Perso nalized Medicine (Development and validation of a radiomic prediction model for TACC3 expression and prognosis in non-small cell lung cancer using contrast-enha nced ...)

西安交通大学第一附属医院报道了普及医学的发现(应用对比增强技术建立和验证非小细胞肺癌TACC3表达和预后的放射学预测模型...)

Robotics & Machine Learning Daily News2024,Issue(Dec.6) :73-74.

First Affiliated Hospital of Xi’an Jiaotong University Reports Findings in Perso nalized Medicine (Development and validation of a radiomic prediction model for TACC3 expression and prognosis in non-small cell lung cancer using contrast-enha nced ...)

西安交通大学第一附属医院报道了普及医学的发现(应用对比增强技术建立和验证非小细胞肺癌TACC3表达和预后的放射学预测模型...)

扫码查看

摘要

由一名新闻记者-机器人与机器学习日报的工作人员新闻编辑每日新闻-药物和治疗的新研究-个性化医疗是一篇报道的主题。据NewsRx记者从中华人民共和国西安发回的新闻报道,Rese Arch指出,“尽管治疗取得了进展,非小细胞肺癌(NSCLC)的预后仍然很差,”而经典的预后指标在预测医学中往往是不足的。转化酸性线圈蛋白-3(TACC3)已被认为是肿瘤进展和免疫浸润的关键因子跨癌症,包括NSCLC。

Abstract

By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News - New research on Drugs and Therapies - Personalized Medicine is the subject of a report.According to news reporting or iginating from Xi’an, People’s Republic of China, by NewsRx correspondents,rese arch stated, “Non-small cell lung cancer (NSCLC) prognosis remains poor despite treatment advances,and classical prognostic indicators often fall short in prec ision medicine. Transforming acidic coiled-coilprotein-3 (TACC3) has been ident ified as a critical factor in tumor progression and immune infiltrationacross c ancers, including NSCLC.”

Key words

Xi’an/People’s Republic of China/Asia/Cancer/Drugs and Therapies/Health and Medicine/Lung Cancer/Lung Diseases an d Conditions/Lung Neoplasms/Non-Small Cell Lung Cancer/Oncology/Personalized Medicine/Personalized Therapy

引用本文复制引用

出版年

2024
Robotics & Machine Learning Daily News

Robotics & Machine Learning Daily News

ISSN:
段落导航相关论文